Brawn Biotech Limited has issued a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically referencing Regulation 36(1)(b).

The disclosure contains two primary communications to shareholders:

i) Notice of 41st Annual General Meeting and Annual Report for FY 2025-26

Pursuant to MCA General Circular No. 03/2025 dated September 22, 2025 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD2/P/CIR/2024/133 dated October 03, 2024, the company is sending the Notice of the 41st Annual General Meeting along with the Annual Report for financial year 2025-26 electronically to shareholders whose email addresses are registered with the Company/Depository Participant(s).

For shareholders who have not registered their email addresses, the Annual Report for FY 2025-26 is available at the following locations:

  • Company Website: www.brawnbiotech.com
  • Stock Exchange Website: www.bseindia.com
  • NSDL e-Voting Portal: www.evoting.nsdl.com
  • CDSL e-Voting Portal: www.evotingindia.com

Shareholders are advised to update their email addresses:

  • Demat holders: Contact respective Depository Participant (DP)
  • Physical holders: Refer to Point No. (ii) for detailed instructions

ii) Re-lodgement of Transfer of Physical Share Certificates

As per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated January 30, 2026, a Special Window has been opened for one year from February 05, 2026 to February 04, 2027. This window is exclusively for re-lodgement of transfer deeds that were originally lodged prior to April 01, 2019 and subsequently rejected, returned, or left unattended due to deficiencies in documentation or process.

Shareholders who wish to re-lodge such transfer requests with necessary corrections may contact the Company's Registrar and Transfer Agent:

RCMC Share Registry Private Ltd. - RTA

B-25/1, Okhla Industrial Area, Phase -2, Near Rana Motors, New Delhi - 110020

Tel: 011-35020465

The document is signed by Priyanka Sharma, Company Secretary and Compliance Officer (Membership No.: A50385) on behalf of Brawn Biotech Limited (CIN No.: L74899DL1985PLC022468).